ELTX
Elicio Therapeutics, Inc. (ELTX) ESG Analysis Analysis (2026)
No material changes this month.
Environmental
ELTX provides no disclosed R&D intensity in the supplied metrics, limiting evidence of peer-leading low-carbon or resource-efficiency investment versus better-disclosed peers.
The absence of reported gross profit margin and FCF margin in the provided data weakens visibility into environmental cost pass-through and capital allocation discipline relative to peers.
Leverage is moderate with net debt to EBITDA at 0.23x, which suggests limited balance-sheet pressure to defer environmental compliance spending versus more levered peers.
No tier-1 filing evidence was provided for emissions, energy use, or waste, so ELTX cannot be assessed as advantaged on core environmental disclosure versus peers.
Social
No workforce, safety, turnover, or diversity metrics were provided, leaving ELTX with materially weaker social transparency than peers that disclose these indicators.
The absence of stock-based compensation intensity in the supplied data limits assessment of employee alignment and retention practices relative to peer companies.
No customer, product safety, or supply-chain social disclosures were provided, which constrains evidence of stronger social risk management versus peers.
Given the limited dataset, ELTX appears neither clearly advantaged nor structurally disadvantaged on social factors, but disclosure depth remains below well-reported peers.
Governance
Debt to equity of 1.78x indicates moderate leverage, which can increase governance scrutiny and capital-allocation discipline versus lower-levered peers.
Net debt to EBITDA of 0.23x suggests manageable financial risk, supporting governance flexibility relative to peers with tighter balance-sheet constraints.
Zero reported stock-based compensation to revenue in the supplied metrics may indicate limited dilution pressure, but peer comparison is constrained without filing-based compensation detail.
No board, audit, ownership, or controversy data were provided, so governance assessment rests mainly on balance-sheet discipline rather than stronger structural oversight versus peers.
Overall Score
ELTX screens as a moderate ESG name versus peers because limited disclosure and only average balance-sheet discipline prevent evidence of a clear ESG advantage.
Score Driver: Limited ESG Disclosure Depth Relative To Peers
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Elicio Therapeutics, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.